{
    "Trade/Device Name(s)": [
        "artus\u00ae Infl A/B RG RT-PCR Kit"
    ],
    "Submitter Information": "QIAGEN GmbH",
    "510(k) Number": "K113323",
    "Predicate Device Reference 510(k) Number(s)": [
        "K110968"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OCC",
        "OOI",
        "JJH"
    ],
    "Summary Letter Date": "October 24, 2011",
    "Summary Letter Received Date": "November 10, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3980"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A virus RNA",
        "Influenza B virus RNA"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "Virus transport medium"
    ],
    "Instrument(s)/Platform(s)": [
        "Rotor-Gene Q MDx",
        "EZ1 Advanced XL"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex real-time RT-PCR",
        "Automated nucleic acid extraction"
    ],
    "Methodologies": [
        "RT-PCR",
        "Molecular detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for artus Infl A/B RG RT-PCR Kit for multiplex qualitative detection and differentiation of Influenza A and B viral RNA in nasopharyngeal swabs using real-time RT-PCR.",
    "Indications for Use Summary": "Qualitative detection and identification of Influenza A and B virus RNA in nasopharyngeal swab specimens from symptomatic patients as an aid in differential diagnosis of respiratory tract infection, in conjunction with clinical and epidemiological risk factors; not intended to detect Influenza C virus.",
    "fda_folder": "Microbiology"
}